SA Tuberculosis Vaccine Initiative

Search

November 2019

14 November 2019 Research: Book Chapter: Diagnosing childhood tuberculosis during a vaccine trial in South Africa. - 14 Nov 2019 - 22:45
SATVI researcher Dr Luabeya awarded ‘C’ rating from the South African National Research Foundation. - 13 Nov 2019 - 15:45
4 November 2019 SATVI Senior Research officer Elisa Nemes promoted to Associate Professor - 4 Nov 2019 - 15:30
4 November 2019 SATVI Senior Research officer promoted to Associate Professor - 4 Nov 2019 - 15:30
4 November 2019 SATVI Senior Research officer promoted to Associate Professor - 4 Nov 2019 - 15:30
4 November 2019 SATVI Senior Research officer promoted to Associate Professor - 4 Nov 2019 - 15:30
4 November 2019 SATVI Senior Research officer promoted to Associate Professor - 4 Nov 2019 - 15:30

October 2019

30 October 2019 Press Conference:Final results M72/AS01E candidate vaccine - 30 Oct 2019 - 19:30
30 October 2019 Press Conference 30 October 2019 Press Conference: Final results M72/AS01E candidate vaccine - 30 Oct 2019 - 13:45
TB Science Conference, 2019: Final results from M72/AS01E candidate vaccine announced - 29 Oct 2019 - 17:00
23 October 2019 Vacancy: Laboratory Technologist - 24 Oct 2019 - 11:45

September 2019

September 2019 Latest research: Plasma Type I IFN Protein Concentrations in Human Tuberculosis - 13 Sep 2019 - 23:00
September 2019 Latest Research Non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis. - 13 Sep 2019 - 22:45
Latest Research: FDG-PET/CT as a non-invasive biomarker for R assessing adequacy of treatment and predicting relapse patients treated for Pulmonary Tuberculosis - 2 Sep 2019 - 15:45

August 2019

27 August 2019 Vacancy: Postdoctoral Fellowship TB Immunology NOW CLOSED - 27 Aug 2019 - 13:15
August 2019 Latest Research Published Results MTBVAC vaccine candidate offer hope for control of tuberculosis in infants - 13 Aug 2019 - 09:30
August 2019 Research: Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy - 2 Aug 2019 - 14:00

July 2019

July 2019 Research: Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state. - 26 Jul 2019 - 15:30
July 2019 Detection of Tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-Infected Persons on Antiretroviral Therapy. - 26 Jul 2019 - 15:15
July 2019 Research Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol. - 26 Jul 2019 - 15:00
June 2019 Research Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents. - 26 Jul 2019 - 14:30
June 2019 Research Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies. - 26 Jul 2019 - 13:30

June 2019

19 June 2019 Latest Keystone Symposium - 19 Jun 2019 - 13:00

May 2019

31 May 2019 Latest Research Moving tuberculosis vaccines from theory to practice - 31 May 2019 - 14:45

April 2019

26 April 2019 New Vacancies added - 26 Apr 2019 - 13:30
16 April 2019 Latest Research: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study - 17 Apr 2019 - 08:15
14 April 2019 SATVI wins Social Responsiveness Award - 14 Apr 2019 - 19:45
Hi Ethan - 2 Apr 2019 - 20:30

March 2019

25 March 2019 World TB Day 3 Peaks Challenge - 25 Mar 2019 - 21:00
25 March 2019 World TB Day 3 Peaks Challenge - 25 Mar 2019 - 21:00
6 March 2019 Latest Research: A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates - 5 Mar 2019 - 20:15
4 March 2019: 2018 Annual Report Now Available - 5 Mar 2019 - 18:45

February 2019

19 January 2019 Research Published: Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria - 4 Feb 2019 - 15:00
17 January 2019 Research Published: Batf2 differentially regulates tissue immunopathology in Type 1 and 2 diseases - 4 Feb 2019 - 14:30

December 2018

11 December 2018 Research Published Building capacity for advances in TB research - 11 Dec 2018 - 14:30
6 December 2018 Research Published: Metabolite changes in blood predict the onset of TB - 7 Dec 2018 - 14:00
3 December 2018 Research Published: Allelic resolution NGS HLA typing of Class I and Class II loci and haplotypes in Cape Town, South Africa. A systematic review and meta-analysis - 4 Dec 2018 - 14:15
1 December 2018 Research Published: Safety and Immunogenicity of early Bacillus Calmette-Guerin (BCG) vaccination in infants who are preterm and/or have low birth weights: - 4 Dec 2018 - 14:00

November 2018

15 November 2018 Research: Commentary WHO Preferred Product Preferences for TB Vaccines - 15 Nov 2018 - 11:30
15 November 2018 Research: Commentary WHO Preferred Product Preferences for TB Vaccines - 15 Nov 2018 - 11:30

Pages

Contact us

General Enquiries:

Tel +27 21 406 6791

Worcester Field Site Office

Tel+ 27 23 346 5400

Email: Information

SATVI Cape Town Offices:

Wernher and Beit South Building, Room S2.01, University of Cape Town , Anzio Road, OBSERVATORY, 7925

Tel: +27 21 406 6791

Fax:+27 21 406 6081

Email: Director

SATVI Worcester Site Office:

SATVI Project Office, University of Cape Town, Brewelskloof Hospital,  Haarlem Street, WORCESTER, 6850.

Tel: +27 23 346 5400

Fax: +27 23 346  5406

Email: Field Site Manager

GPS coordinates -33.620455, 19.458576

Map to Worcester Field Office